Purchases and Sales Made in Q3 2023 in Kiniksa Pharmaceuticals, Ltd. (KNSA)
This table provides information about the institutional ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA) during Q3 2023. The information is specifically focused on institutions that hold shares of Kiniksa Pharmaceuticals, Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-43K- 35.83% |
$585K - $868K
|
76.9K
$1.53M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-43.4K- 4.78% |
$592K - $877K
|
866K
$17.3M
|
|
|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-115K- 51.94% |
$1.57M - $2.32M
|
106K
$2.12M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-120K- 59.35% |
$1.63M - $2.42M
|
82K
$1.64M
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-128K- 4.15% |
$1.75M - $2.59M
|
2.96M
$59M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-167K- 51.39% |
$2.28M - $3.38M
|
158K
$3.15M
|
|
|
Nov 14, 2023
Q3 2023
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-187K- 36.68% |
$2.55M - $3.79M
|
324K
$6.45M
|
|
|
Nov 14, 2023
Q3 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-301K- 8.9% |
$4.1M - $6.07M
|
3.08M
$61.3M
|
|
|
Nov 14, 2023
Q3 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-362K- 69.72% |
$4.93M - $7.32M
|
157K
$3.14M
|
|
|
Nov 14, 2023
Q3 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-378K- 55.51% |
$5.14M - $7.63M
|
303K
$6.03M
|